Материал из Wiki Mininuniver
Перейти к навигацииПерейти к поиску
|
|
| (не показана 1 промежуточная версия этого же участника) |
| Строка 1: |
Строка 1: |
| − | Non-Hodgkin's lymphoma (NHL), a cancer affecting the lymphatic system, is the second-fastest-rising cancer in the United States. Incidence rates have nearly doubled over the past 30 years. It is estimated that 360,000 Americans are presently living with NHL, and about 58,000 new instances are expected to occur in the United States this year.<br><br>NHL is challenging to target and treat, as the disease can be found all through the body in any blood-filtering tissue such as bone marrow. Patients usually have many relapses, which means the cancer returns many instances. This tends to make it extremely crucial for patients, their caretakers and their loved ones to talk to a physician about all accessible therapy possibilities and to get access to the most recent therapies.<br><br>NHL patients are traditionally treated with chemotherapy and/or radiation therapy. While these treatments destroy cancer cells, they also destroy surrounding healthy cells. Furthermore, chemotherapy and [http://www.onetoonecancercenter.com/ cancer treatment florida] radiation therapy can take up to 5 months to full and might demand patients to remain in the hospital.<br><br>An innovative class of drugs is harnessing the immune method to fight NHL. Radioimmunotherapy (RIT) is a promising area of cancer remedy that combines the specificity of monoclonal antibodies (comparable to other antibodies the immune program makes to fight infection) with the cell-killing potential of radiation. When injected into a patient, these radiation-carrying antibodies seek out and bind to particular tumor cells, and then deliver radiation directly to those and surrounding cells.<br><br>Two RIT items have been approved by the U.S. Food and Drug Administration (FDA). These merchandise [http://www.onetoonecancercenter.com/ cyberknife radiosurgery] are completed in just a single therapy regimen, lasting 1-2 weeks, so patients don't require to regularly return to their doctor's office for treatment on a weekly or semiweekly basis. Coupled with the truth that RIT can be administered on an outpatient basis, these therapies offer far more convenience for patients and their families. Recent scientific studies have shown that NHL patients may possibly benefit most from these therapies when they are employed early in the treatment of NHL, prior [http://www.onetoonecancercenter.com/ cancer treatment center] to multiple courses of chemotherapy.<br><br>RIT delivers radiation to B-cells by recognizing and attaching to the CD20 antigen.
| + | Content removed |
Текущая версия на 18:05, 18 декабря 2025
